Discover how RBX2660, a groundbreaking microbiome therapy, is clearing VRE in patients with recurrent Clostridium difficile infection and revolutionizing infection treatment.
Exploring the impact of VRE colonization on allogeneic hematopoietic cell transplantation outcomes and survival rates.